LT
Laurentide Therapeutics Inc.
SEC filingPharmaceuticals · Atlanta, GA
Amount raised$100Ksold at filing
Total offering$100K$1 still open
Investors in the raise7count reported to the SEC
FiledSep 28, 2026first sale Aug 20, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Horace NalleExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.